# FutureChem signs $1.26M radiopharmaceutical supply contract with Avid

FutureChem has signed a contract with Eli Lilly subsidiary Avid to manufacture and supply radiopharmaceuticals for Alzheimer's diagnostic clinical trials in South Korea, valued at $1.259 million.

- Type: Contract
- Announced: 2022-04-18
- Where: South Korea, South Korea
- Value: $1.26M
- Status: announced
- Products: radiopharmaceuticals for Alzheimer's diagnosis
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eli Lilly](https://endata.com/companies/32564.md) (partner)
- [AVID Radiopharmaceuticals](https://endata.com/companies/32565.md) (customer)
- [FutureChem](https://endata.com/companies/62340.md) (supplier)

## Sources

- [asiae.co.kr](https://www.asiae.co.kr/article/2022041811471183510), 2022-04-18: "계약 규모는 125만9000달러(약 15억4000만원)로, 국내 임상시험에 필요한 알츠하이머 진단용 방사성 의약품 위탁생산 및 공급계약이다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.